Takeda to divest consumer health care business to Blackstone for $2.3bn
Japanese pharmaceutical company Takeda has agreed to sell its subsidiary Takeda Consumer Healthcare Company (TCHC) to Oscar A-Co KK for JPY 242bn ($2.3bn). Oscar A-Co KK is controlled